Five patients with type 2 diabetes, three of them treated with insulin and two with oral antidiabetic drugs, receiving imatinib due to chronic myeolid leukaemia are reported. Treatment with imatinib 400 mg/day for 7 to 37 (mean 24.2) months had no positive effect on clinical course of type 2 diabetes.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
type diabetes
8
[no influence
4
influence imatinib
4
imatinib type
4
type diabetes]
4
diabetes] patients
4
patients type
4
diabetes three
4
three treated
4
treated insulin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!